|Title:||Principal Scientist, Translational Science|
About SwanBio Therapeutics
SwanBio is a privately held, newly established biotechnology company focused on the discovery and development of innovative gene therapy products for the treatment of central nervous system (CNS) disorders and diseases. SwanBio has a deeply experienced leadership team and is building an open, innovative culture that trusts its people, processes and science to deliver scientific, clinical and business success. .SwanBio’s lead investor is Syncona, a premiere investment partner focused on building companies delivering transformational healthcare treatments. Syncona has a deep pool of capital and they are established leaders in the development of genetic medicine. In particular, they present a legacy of success in long term investment strategies for companies in the Gene and Cell Therapy space. Our goal is to become a world-leader in treating neurodegenerative diseases. With locations in Philadelphia and Boston, the SwanBio Team is building a strong pipeline of gene therapy development programs with a directed focus on critical unmet medical needs for CNS diseases. SwanBio offers all team members both competitive compensation and benefits.
The primary responsibility will be to act as the Principal Scientist managing early through late stage translational development of preclinical programs in support advancement of Swan Bio's pipeline. This individual will support the preclinical in vitro and early phase in vivo effort to validate the potential of novel therapeutics for the organization. The role will have significant input into delivering on the translational strategy, as well as analyzing, collating and communicating data to multiple internal and external stakeholders. The candidate will also participate in authoring relevant sections of documents pertaining to translational science/correlative studies in support of regulatory submissions to governmental regulatory agencies and will contribute to external publications. The role will also lead the translational research efforts, design and execute experiments, supervise laboratory personnel, present results internally and externally and manage collaborations and CROs.
In this role you will:
- Contribute to and implement a translational drug development strategy to support nonclinical development during all stages of drug development up to GLP Tox.
- Design, implement, report and interpret nonclinical study data of gene therapy drug candidates in support of regulatory submissions
- Manage multiple projects as needed across the organization.
- Manage others to meet project timelines and to develop technical and trouble shooting skills
- Provide scientific expertise, guidance and strategy to successfully bring programs to milestones for Go/No Go decisions. Provide expert level guidance in designing, implementing, and interpreting in vitro and in vivo cell biology, biochemistry and biomarker related studies for rare neurologic diseases.
- Collaborate with others to develop, optimize, validate and execute biochemical and/or cellular assays to support drug discovery projects, including assay development, and running of assays. Interact/collaborate with CROs, as necessary to ensure appropriate/timely progression of projects
- Prepare study synopses, protocols, study reports and regulatory documents to support nonclinical development
- Effectively communicate nonclinical findings and their relevance to senior management, project teams, collaborators, and regulatory agencies (i.e. FDA, EMA, PMDA)
- Participate in multi-disciplinary drug development teams and may lead sub-teams
- A Ph.D. degree in Neuroscience, Biochemistry, Molecular Biology, Cell Biology or Immunology or a combination of education and experience,
- 3-5 years drug discovery experience, preferably in gene therapy
- Previous experience in conducting In Vivo research using the latest drug discovery technologies and advances in science
- Possess a curiosity in exploring new path for gene therapy development, be bold in proposing creative experimental designs and ideas.
- Ability to manage multiple project in a fast-moving and results-oriented environment
- Ability to analyze and troubleshoot in an independent manner
- Work collaboratively with multifunctional teams and will be relentless in pursuing successful outcomes
- Prior management/supervisory experience preferred, but not required
- Knowledge and experience making contributions to advance Gene therapy projects from in vivo proof-of concept through clinical candidate selection in support of IND submission.
- Significant experience in being resourceful while working in a small biotech environment
- Proven ability to work independently and effectively plan and organize work activities and prioritize task completion to meet schedules and deadline
- Ability to manage outside vendors
- Prior experience in writing IND modules preferred, but not required
- Highly developed credible leadership skills
- Excellent scientific knowledge and drive
- Ability to make sound and timely strategic decisions, prioritise, plan projects and deliver to timelines
- Strong team player with ability to work in cross-functional teams and a highly matrixed environment
- Excellent communication skills (both written and verbal)
- Development and implementation of the translational sciences strategy for non-clinical projects under the guidance of the SVP of Translational Sciences
- Possess a mind-set of no job too big or too small
The successful candidate will enjoy a competitive base salary and the opportunity to participate in incentive compensation programs including bonus and stock option plans. Additionally, SwanBio Therapeutics offers all team members a comprehensive benefits program including medical, dental, vision care, 401(k), paid vacation and holiday time.
SwanBio Therapeutics is an equal opportunity employer